Evidence map›Paper›PMID 30265959›Full record

ArticleEuropean journal of medicinal chemistry2018

Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.

Yusuke Kato, Niyada Hin, Nobuo Maita, Ajit G Thomas, Sumire Kurosawa, Camilo Rojas, Kazuko Yorita, Barbara S Slusher, Kiyoshi Fukui, Takashi Tsukamoto

Open access · greenAbstract read
In one paragraph

Article in European journal of medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yusuke KatoInstitute for Enzyme Research, Tokushima University, Tokushima, 770-8503, Japan.
Niyada HinJohns Hopkins Drug Discovery, Johns Hopkins University, Baltimore, MD, 21205, USA.
Nobuo MaitaInstitute for Enzyme Research, Tokushima University, Tokushima, 770-8503, Japan.
Ajit G ThomasJohns Hopkins Drug Discovery, Johns Hopkins University, Baltimore, MD, 21205, USA.
Sumire KurosawaInstitute for Enzyme Research, Tokushima University, Tokushima, 770-8503, Japan.
Camilo RojasJohns Hopkins Drug Discovery, Johns Hopkins University, Baltimore, MD, 21205, USA.
Kazuko YoritaInstitute for Enzyme Research, Tokushima University, Tokushima, 770-8503, Japan.
Barbara S SlusherJohns Hopkins Drug Discovery, Johns Hopkins University, Baltimore, MD, 21205, USA; Department of Neurology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Kiyoshi FukuiInstitute for Enzyme Research, Tokushima University, Tokushima, 770-8503, Japan. Electronic address: kiyo.fukui@tokushima-u.ac.jp.
Takashi TsukamotoJohns Hopkins Drug Discovery, Johns Hopkins University, Baltimore, MD, 21205, USA; Department of Neurology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Johns Hopkins University · USTokushima University · JP

Funding

DAAO Inhibitors for the treatment of SchizophreniaR01MH091387 · NIMH · JOHNS HOPKINS UNIVERSITY · PI TSUKAMOTO, TAKASHI · 2011 to 2014
$2.1M
NIMH NIH HHS R01 MH091387
6 · The paper itself

Abstract

A series of thiophene-2-carboxylic acids and thiophene-3-carboxylic acids were identified as a new class of DAO inhibitors. Structure-activity relationship (SAR) studies revealed that small substituents are well-tolerated on the thiophene ring of both the 2-carboxylic acid and 3-carboxylic acid scaffolds. Crystal structures of human DAO in complex with potent thiophene carboxylic acids revealed that Tyr224 was tightly stacked with the thiophene ring of the inhibitors, resulting in the disappearance of the secondary pocket observed with other DAO inhibitors. Molecular dynamics simulations of the complex revealed that Tyr224 preferred the stacked conformation irrespective of whether Tyr224 was stacked or not in the initial state of the simulations. MM/GBSA indicated a substantial hydrophobic interaction between Tyr244 and the thiophene-based inhibitor. In addition, the active site was tightly closed with an extensive network of hydrogen bonds including those from Tyr224 in the stacked conformation. The introduction of a large branched side chain to the thiophene ring markedly decreased potency. These results are in marked contrast to other DAO inhibitors that can gain potency with a branched side chain extending to the secondary pocket due to Tyr224 repositioning. These insights should be of particular importance in future efforts to optimize DAO inhibitors with novel scaffolds.

Indexed as

Carboxylic AcidsCrystallography, X-RayD-Amino-Acid OxidaseDose-Response Relationship, DrugEnzyme InhibitorsHumansModels, MolecularMolecular StructureStructure-Activity RelationshipThiophenes2-thiophene carboxylic acidCarboxylic AcidsD-Amino-Acid OxidaseDAO protein, humanEnzyme InhibitorsThiophenesDrug discoveryFlavoenzymeMolecular dynamicsSchizophreniaX-ray crystallography

Identifiers

PMID30265959
PMCPMC6193832
OpenAlexW2892039487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.